Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium
- 1 September 1991
- journal article
- Published by Springer Nature in Heart and Vessels
- Vol. 6 (3) , 158-167
- https://doi.org/10.1007/bf02058281
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effect of OPC-8490 on the membrane potentials and membrane currents of single guinea-pig myocytesCardiovascular Drugs and Therapy, 1990
- A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failureCardiovascular Drugs and Therapy, 1990
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.Japanese Heart Journal, 1989
- Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failureHeart and Vessels, 1986
- Hemodynamic Effects of MDL 17,043, a New Cardiotonic Agent, in Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1983
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978